0001868267-21-000001.txt : 20210618 0001868267-21-000001.hdr.sgml : 20210618 20210617182325 ACCESSION NUMBER: 0001868267-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210618 DATE AS OF CHANGE: 20210617 EFFECTIVENESS DATE: 20210618 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bluejay Therapeutics, Inc. CENTRAL INDEX KEY: 0001868267 IRS NUMBER: 844654221 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-403422 FILM NUMBER: 211026292 BUSINESS ADDRESS: STREET 1: 45 FALKIRK LANE CITY: HILLSBOROUGH STATE: CA ZIP: 94010 BUSINESS PHONE: 6502185487 MAIL ADDRESS: STREET 1: 45 FALKIRK LANE CITY: HILLSBOROUGH STATE: CA ZIP: 94010 D 1 primary_doc.xml X0708 D LIVE 0001868267 Bluejay Therapeutics, Inc. 45 FALKIRK LANE HILLSBOROUGH CA CALIFORNIA 94010 6502185487 DELAWARE None None Corporation true 2019 Keting Chu 45 Falkirk Lane Hillsborough CA CALIFORNIA 94010 Executive Officer Director Other Technology Decline to Disclose 06b false 2021-06-10 false true false 0 24239991 19239990 5000001 false 6 0 0 0 false Bluejay Therapeutics, Inc. /s/Keting Chu Keting Chu CEO 2021-06-17